Jump to content

Talk:Olanzapine: Difference between revisions

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia
Content deleted Content added
Word2013 (talk | contribs)
→‎Controversy: new section
Line 24: Line 24:
:what purpose would that serve? <span style="font-size: smaller;" class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/82.45.216.153|82.45.216.153]] ([[User talk:82.45.216.153|talk]]) 00:34, 15 January 2013 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot-->
:what purpose would that serve? <span style="font-size: smaller;" class="autosigned">— Preceding [[Wikipedia:Signatures|unsigned]] comment added by [[Special:Contributions/82.45.216.153|82.45.216.153]] ([[User talk:82.45.216.153|talk]]) 00:34, 15 January 2013 (UTC)</span><!-- Template:Unsigned IP --> <!--Autosigned by SineBot-->


== "Illegal promotion" paragraph removed ==


I've removed the paragraph below. I have no opinion on the drug or its use, or knowledge of the "qui tam" (class action) suits alleged, but it lacks clarity, citations, context, and doesn't make much sense. Please restore the paragraph if you have better sources and wording. [[Special:Contributions/201.171.122.70|201.171.122.70]] ([[User talk:201.171.122.70|talk]]) 09:13, 25 January 2013 (UTC)
:===(removed paragraph) Illegal promotion in US===
:The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The ''[[qui tam]]'' lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. [[Food and Drug Administration]] (FDA), to be a serious crime that undermines their role in drug regulation and public safety.<ref name = "Off-label" />
:The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The ''[[qui tam]]'' lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. [[Food and Drug Administration]] (FDA), to be a serious crime that undermines their role in drug regulation and public safety.<ref name = "Off-label" />
Remember the Zyprexa scandal.
The Eli Lilly company made an astounding $70 BILLION on Zyprexa that they PUSHED on the elderly and underage children (*Viva Zyprexa* Lilly sales rep slogan) with wanton disregard for the side effects
*FIVE at FIVE*
The Zyprexa antipsychotic drug,whose side effects can include weight gain and diabetes, was sold to Veterans,children in foster care, elderly in nursing homes.
*Five at Five* was the Zyprexa sales rep slogan, meaning *5mg dispensed at 5pm would keep patients quiet*.
*Tell the truth don't be afraid*.
-- Daniel Haszard
FMI http://www.zyprexa-victims.com


== Controversy ==
== Controversy ==

Revision as of 06:03, 20 April 2013

WikiProject iconPharmacology B‑class High‑importance
WikiProject iconThis article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.
BThis article has been rated as B-class on Wikipedia's content assessment scale.
HighThis article has been rated as High-importance on the project's importance scale.
WikiProject iconMedicine B‑class High‑importance
WikiProject iconThis article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.
BThis article has been rated as B-class on Wikipedia's content assessment scale.
HighThis article has been rated as High-importance on the project's importance scale.

Untitled

Here's an important article that just came out in the NY Times http://www.nytimes.com/2006/12/18/business/18drug.html?hp&ex=1166504400&en=abbfa89f1f363c93&ei=5094&partner=homepage — Preceding unsigned comment added by 71.206.230.233 (talk)

The Chemistry Section

Someone needs to explain in great detail using descriptive words to explain how this chemical is made or synthesized in language that the lay person can understand. A chart is not enough and the section alludes that there are many methods to synthesis this molecule so therefore all methods should be explained. 2602:306:C518:62C0:5C06:758E:E477:60D6 (talk) 23:18, 31 July 2012 (UTC)[reply]

what purpose would that serve? — Preceding unsigned comment added by 82.45.216.153 (talk) 00:34, 15 January 2013 (UTC)[reply]


The criminal information alleged that Zyprexa was promoted (1999-2003) in nursing homes and assisted-living facilities for the treatment of disorders such as dementia, Alzheimer’s dementia, depression, anxiety, and sleep problems, and behavioral symptoms such as agitation, aggression, and hostility. The qui tam lawsuits alleged that Zyprexa was promoted (1999-2005) for use in patients of all ages and for the treatment of anxiety, irritability, depression, nausea, Alzheimer’s and other mood disorders. Off-label promotion of pharmaceutical drugs is considered, by the U.S. Food and Drug Administration (FDA), to be a serious crime that undermines their role in drug regulation and public safety.[1]

Remember the Zyprexa scandal. The Eli Lilly company made an astounding $70 BILLION on Zyprexa that they PUSHED on the elderly and underage children (*Viva Zyprexa* Lilly sales rep slogan) with wanton disregard for the side effects

  • FIVE at FIVE*
The Zyprexa antipsychotic drug,whose side effects can include weight gain and diabetes, was sold to Veterans,children in foster care, elderly in nursing homes. 
*Five at Five* was the Zyprexa sales rep slogan, meaning *5mg dispensed at 5pm would keep patients quiet*. 
  • Tell the truth don't be afraid*.

-- Daniel Haszard FMI http://www.zyprexa-victims.com

Controversy

Jimmy Wales will help soon. This medication has serious side effects. --Word2013 (talk) 13:12, 19 April 2013 (UTC)[reply]

  1. ^ Cite error: The named reference Off-label was invoked but never defined (see the help page).